The transition to IVDR introduces new challenges for IVD manufacturers, with stricter requirements and revised timelines to ensure compliance
Discover what the EMA’s updated benefit-risk guidelines for veterinary medicine mean in 2025 and how they impact manufacturers, veterinarians, and.
Small pharma companies rely on CROs for expertise, cost-effectiveness, flexibility, and strong communication in clinical trials.
Challenges of OS obsolescence in pharma: cybersecurity risks, compliance issues, and the need to migrate from Windows 10 to ensure security and.
Key post-Brexit UK regulations for European veterinary businesses: compliance, registration, and pharmacovigilance
The pharmaceutical industry uses data, IoT, and AI/ML to boost efficiency and accuracy. For this reason, maintaining quality and security is crucial.
Discover PQE’s 'Glocal' validation approach: a balanced strategy combining global standards with local customization to optimize time, cost, and.
Discover the limitations of RABS vs. isolators and why transitioning to isolator systems is essential for meeting evolving sterile processing GMP.
Medical cannabis is commonly used for pain management, oncological symptoms, anxiety and neurodegenerative diseases.
Discover key changes in EU PHV for 2023, including stricter regulations, digital tools, and compliance updates for human and veterinary medicine.
